She was started on intravenous methylprednisolone (IVMP) and mesalamine with a quick favorable response ... A differential diagnosis should also be considered with IBD [Ulcerative colitis/Chron’s ...

SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness ...

Data presented at the 2025 Crohn’s and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

Bloating is a common digestive issue affecting people of all ages, however, the experience becomes more frequent and severe ...

Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of ...

Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...

Up to 25,000 people with ulcerative colitis (UC) in England could be in line for treatment with Pfizer’s once-daily oral therapy Velsipity, after NICE recommended its use by the NHS. The new ...

Ulcerative proctitis can be extremely challenging to manage. The use of oral medications can frequently be associated with systemic side effects, while the use of topical agents are rarely ...

Ulcerative colitis is a chronic, immune-mediated disorder of the colon and rectum characterized by mucosal inflammation that damages the bowel wall surface. Current therapeutic options include ...

Email: Karel.Geboes{at}uz.kuleuven.ac.be BACKGROUND Evaluation of histological activity in ulcerative colitis needs to be reproducible but has rarely been tested. This could be useful both clinically ...

Older adults with moderate to severe IBD can achieve remission with JAK inhibitors, according to a study presented at Crohn’s & Colitis Congress.